OBJECTIVE: Growing evidence suggests that a phenotypic switch converting pancreatic acinar cells to duct-like cells can lead to pancreatic intraepithelial neoplasia and eventually to invasive pancreatic ductal adenocarcinoma. Histologically, the onset of this switch is characterised by the co-expression of acinar and ductal markers in acini, a lesion called acinar-to-ductal metaplasia (ADM). The transcriptional regulators required to initiate ADM are unknown, but need to be identified to characterise the regulatory networks that drive ADM. In this study, the role of the ductal transcription factors hepatocyte nuclear factor 6 (HNF6, also known as Onecut1) and SRY-related HMG box factor 9 (Sox9) in ADM was investigated. DESIGN: Expression of HNF6 and Sox9 was measured by immunostaining in normal and diseased human pancreas. The function of the factors was tested in cultured cells and in mouse models of ADM by a combination of gain and loss of function experiments. RESULTS: Expression of HNF6 and Sox9 was ectopically induced in acinar cells in human ADM as well as in mouse models of ADM. HNF6 and, to a lesser extent, Sox9 were required for repression of acinar genes, for modulation of ADM-associated changes in cell polarity and for activation of ductal genes in metaplastic acinar cells. CONCLUSIONS: HNF6 and Sox9 are new biomarkers of ADM and constitute candidate targets for preventive treatment in cases when ADM may lead to cancer. This work also shows that ectopic activation of transcription factors may underlie metaplastic processes occurring in other organs.
OBJECTIVE: Growing evidence suggests that a phenotypic switch converting pancreatic acinar cells to duct-like cells can lead to pancreatic intraepithelial neoplasia and eventually to invasive pancreatic ductal adenocarcinoma. Histologically, the onset of this switch is characterised by the co-expression of acinar and ductal markers in acini, a lesion called acinar-to-ductal metaplasia (ADM). The transcriptional regulators required to initiate ADM are unknown, but need to be identified to characterise the regulatory networks that drive ADM. In this study, the role of the ductal transcription factors hepatocyte nuclear factor 6 (HNF6, also known as Onecut1) and SRY-related HMG box factor 9 (Sox9) in ADM was investigated. DESIGN: Expression of HNF6 and Sox9 was measured by immunostaining in normal and diseased human pancreas. The function of the factors was tested in cultured cells and in mouse models of ADM by a combination of gain and loss of function experiments. RESULTS: Expression of HNF6 and Sox9 was ectopically induced in acinar cells in humanADM as well as in mouse models of ADM. HNF6 and, to a lesser extent, Sox9 were required for repression of acinar genes, for modulation of ADM-associated changes in cell polarity and for activation of ductal genes in metaplastic acinar cells. CONCLUSIONS:HNF6 and Sox9 are new biomarkers of ADM and constitute candidate targets for preventive treatment in cases when ADM may lead to cancer. This work also shows that ectopic activation of transcription factors may underlie metaplastic processes occurring in other organs.
Authors: P Jacquemin; S M Durviaux; J Jensen; C Godfraind; G Gradwohl; F Guillemot; O D Madsen; P Carmeliet; M Dewerchin; D Collen; G G Rousseau; F P Lemaigre Journal: Mol Cell Biol Date: 2000-06 Impact factor: 4.272
Authors: Howard C Crawford; Charles R Scoggins; M Kay Washington; Lynn M Matrisian; Steven D Leach Journal: J Clin Invest Date: 2002-06 Impact factor: 14.808
Authors: R H Hruban; N V Adsay; J Albores-Saavedra; C Compton; E S Garrett; S N Goodman; S E Kern; D S Klimstra; G Klöppel; D S Longnecker; J Lüttges; G J Offerhaus Journal: Am J Surg Pathol Date: 2001-05 Impact factor: 6.394
Authors: Ronjon Paul; Rex C Haydon; Hongwei Cheng; Akira Ishikawa; Nikola Nenadovich; Wei Jiang; Lan Zhou; Benjamin Breyer; Tao Feng; Purnendu Gupta; Tong-Chuan He; Frank M Phillips Journal: Spine (Phila Pa 1976) Date: 2003-04-15 Impact factor: 3.468
Authors: Dale E Bockman; Junchao Guo; Peter Büchler; Michael W Müller; Frank Bergmann; Helmut Friess Journal: Lab Invest Date: 2003-06 Impact factor: 5.662
Authors: Sofie De Groef; Gunter Leuckx; Naomi Van Gassen; Willem Staels; Ying Cai; Yixing Yuchi; Violette Coppens; Nico De Leu; Yves Heremans; Luc Baeyens; Mark Van de Casteele; Harry Heimberg Journal: J Vis Exp Date: 2015-08-07 Impact factor: 1.355
Authors: John F Eisses; Angela Criscimanna; Zachary R Dionise; Abrahim I Orabi; Tanveer A Javed; Sheharyar Sarwar; Shunqian Jin; Lili Zhou; Sucha Singh; Minakshi Poddar; Amy W Davis; Akif Burak Tosun; John A Ozolek; Mark E Lowe; Satdarshan P Monga; Gustavo K Rohde; Farzad Esni; Sohail Z Husain Journal: Am J Pathol Date: 2015-10-23 Impact factor: 4.307
Authors: Janel L Kopp; Guido von Figura; Erin Mayes; Fen-Fen Liu; Claire L Dubois; John P Morris; Fong Cheng Pan; Haruhiko Akiyama; Christopher V E Wright; Kristin Jensen; Matthias Hebrok; Maike Sander Journal: Cancer Cell Date: 2012-11-29 Impact factor: 31.743